IRIDEX CORP (IRIX) director adds 20,000 shares in Dec. 15, 2025 purchase
Rhea-AI Filing Summary
IRIDEX CORP director William M. Moore purchased 20,000 shares of the company’s common stock on December 15, 2025. The transaction is reported as a purchase and was executed at a weighted average price, with individual trades occurring at prices ranging from $0.98 to $0.9885 per share.
After this transaction, Moore beneficially owns 249,550 shares directly. In addition, 69,300 shares are held indirectly through his spouse, and 81,150 shares are held indirectly through family trusts.
Positive
- None.
Negative
- None.
FAQ
What insider transaction did IRIDEX CORP (IRIX) report for William M. Moore?
IRIDEX CORP director William M. Moore bought 20,000 shares of common stock on December 15, 2025. The transaction is classified as a purchase of non-derivative common shares.
When did the IRIDEX CORP (IRIX) director's stock purchase occur?
The purchase took place on December 15, 2025. On that date, William M. Moore acquired 20,000 shares of IRIDEX CORP common stock.
How many IRIDEX CORP (IRIX) shares does William M. Moore own after the transaction?
After the transaction, Moore beneficially owns 249,550 shares directly. He also has 69,300 shares held indirectly through his spouse and 81,150 shares held indirectly through trusts.
At what prices were the IRIDEX CORP (IRIX) shares purchased in this insider trade?
The reported price is a weighted average based on multiple trades. Individual purchases were made at prices ranging from $0.98 to $0.9885 per share.
What is William M. Moore's relationship to IRIDEX CORP (IRIX)?
William M. Moore is a director of IRIDEX CORP. The filing identifies his relationship to the issuer as a director, with the corresponding box marked.
How are William M. Moore's indirect IRIDEX CORP (IRIX) holdings structured?
Moore's indirect holdings include shares held by his spouse and by trusts. He has 69,300 shares held by his spouse and 81,150 shares held through family trusts as tenants in common.